Insights - Affimed (AFMD) announced Q2 results today, which showed that the pipeline is progressing as planned. Below is an update for each candidate: AFM13: On Track … Continue Reading
Read NowInsights - Fennec Pharmaceuticals (FENC:NASDAQ) (FRX.TO:TSX) released the results of its long anticipated Phase 3 study. Interim data showed Fennec’s drug, sodium thiosulfate (“STS”) significantly reduces chemotherapy … Continue Reading
Read NowResearch - Paratek Pharmaceuticals (PRTK) released their top-line, OASIS-2 results after the bell yesterday, comparing oral omadacycline to linezolid in ABSSSI infections. Omadacycline achieved all primary and … Continue Reading
Premium: Read NowResearch - A tremendous breakout for pharma and biotech stocks is underway, and it makes sense. We’ve discussed this in our recent webinars that we think the … Continue Reading
Premium: Read NowResearch - Selecta’s (SELB) data, presented at EULAR today, look great. Last week we outlined what to look for. Here’s a quick summary of today’s data. SEL-212 … Continue Reading
Premium: Read NowResearch - Editor’s Note – We’ll be transitioning to using Team@PropThink.com for future email communications. Make sure this is added to your address book to insure proper … Continue Reading
Premium: Read NowResearch - ASCO is in full swing, which we covered in our last two webinars (April / May). Some of these are playing out today, most notably … Continue Reading
Premium: Read Now
